Skip to content
Disclosery

PharVision Advisers, LLC: ECVT position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of PharVision Advisers, LLC on ECVT, newest first. How the timeline and the estimate are built.

PharVision Advisers, LLC held 0 ECVT shares at 2025-12-31 per its 13F-HR filed 2026-02-17.

the latest 13F is the newest step

  1. period ended2025-12-31
    13F 0 shares
    Change vs previous 13F -11,580 shares

    13F-HR 0001420506-26-000567 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-09-30
    13F 11,580 shares
    Change vs previous 13F +11,580 shares

    0.06% of the 13F portfolio, value $101,441.

    13F-HR 0001420506-25-003453 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-03-31
    13F 0 shares
    Change vs previous 13F -58,121 shares

    13F-HR 0001420506-25-001232 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  4. period ended2024-12-31
    13F 58,121 shares
    Change vs previous 13F not available

    0.38% of the 13F portfolio, value $444,044.

    13F-HR 0001420506-25-000626 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).